The curative treatment and organ preservation in advanced squamous cell carcinoma of the oropharynx is multimodal. It involves induction chemotherapy and depending on the response radio-chemotherapy or surgery. The combination of these methods has important functional consequences. The aim of this prospective pilot study is to describe swallowing, speech, but also patients' quality of life before and after therapeutic management (existing studies measuring these functions after treatment but not before).
This study will not change the patient's treatment. This will just be an evaluation, before any treatment, his ability to swallow, speak then, as in normal practice, after 3, 6 and 12 months after treatment.
Study Type
OBSERVATIONAL
Enrollment
12
This study will not change the patient's treatment. This will just be an evaluation, before any treatment, his ability to swallow, speak, then his quality of life, as in normal practice, after 3, 6 and 12 months after treatment.
CHu de SAINT-ETIENNE
Saint-Etienne, France
change from swallowing disorder
A swallowing disorder will be determined by conducting a video-endoscopy and voluntary swallowing reflex (composite measure)
Time frame: between day 0 and 1 year
Change from phonation disorder
Phonation disorders will be evaluated by the scale "Voice Handicap Index" (composite measure)
Time frame: between day 0 and 1 year
Change from quality of life
The quality of life will be assessed by the Quality of Life scale EORTC QLQ-C30 and QLC-HN35 (composite measure)
Time frame: between day 0 and 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.